Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors

Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are rare diseases encompassing pancreatic (PanNETs) and ileal NETs (SINETs), characterized by heterogeneous somatostatin receptors (SSTRs) expression. Treatments for inoperable GEP-NETs are limited, and SSTR-targeted Peptide Receptor Radionuc...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Martine Bocchini, Marcella Tazzari, Sara Ravaioli, Filippo Piccinini, Flavia Foca, Michela Tebaldi, Fabio Nicolini, Ilaria Grassi, Stefano Severi, Raffaele Adolfo Calogero, Maddalena Arigoni, Joerg Schrader, Massimiliano Mazza, Giovanni Paganelli
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2023-05-01
Cyfres:	Frontiers in Oncology
Pynciau:	pancreatic neuroendocrine tumors PRRT (peptide receptor radionuclide therapy) miRNA – microRNA functional imaging (positron-emission tomography) SSTR2
Mynediad Ar-lein:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1136331/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!